Cancer burden may be changing for people living with HIV
The total number of cancer cases diagnosed among people living with the human immunodeficiency virus…
Browsing: AACR 2017
New immunotherapy combination shows promise for patients with advanced melanoma
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
Five-year Survival Rate For Nivolumab-treated Advanced Lung Cancer Patients Much Higher Than Historical Rate
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with…
Phase II trial: Rice bran adds microbiome diversity, slows growth of colon cancer cells
University of Colorado Cancer Center researchers presented the results of a phase II clinical trial…
AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…
AACR 2017: Wearable medical device improves survival for patients with glioblastoma
Patients with glioblastoma who wore a medical device that delivers alternating electrical fields in addition…
AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease burden in leukaemia patients
Although most patients with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced complete response after treatment…
AACR 2017: Regular aspirin use is associated with lower cancer mortality
Long-term, regular aspirin use was associated with reduced risk of death from several different kinds…
AACR 2017: Many childhood cancer survivors carry mutations in cancer risk genes, raising chance of later disease
Whole-genome sequencing conducted on a large cohort of childhood cancer survivors indicated that many survivors…
AACR 2017: Deploying anti-bacterial immune responses to kill cancer
A recent small trial in 15 cancer patients with advanced soft-tissue sarcomas aimed to find…